1. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Issue 7 (July 2020) Authors: Folegatti, Pedro M; Bittaye, Mustapha; Flaxman, Amy; Lopez, Fernando Ramos; Bellamy, Duncan; Kupke, Alexandra; Mair, Catherine; Makinson, Rebecca; Sheridan, Jonathan; Rohde, Cornelius; Halwe, Sandro; Jeong, Yuji; Park, Young-Shin; Kim, Jae-Ouk; Song, Manki; Boyd, Amy; Tran, Nguyen; Silman, Daniel... Journal: Lancet infectious diseases Issue: Volume 20:Issue 7(2020) Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗